Specify a stock or a cryptocurrency in the search bar to get a summary
Tectonic Therapeutic, Inc.
TECXTectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts. Address: 490 Arsenal Way, Watertown, MA, United States, 02472
Analytics
WallStreet Target Price
60 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures TECX
Dividend Analytics TECX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TECX
Stock Valuation TECX
Financials TECX
Results | 2019 | Dynamics |